Hyposialylation Must Be Considered to Develop Future Therapies in Autoimmune Diseases

Autoimmune disease development depends on multiple factors, including genetic and environmental. Abnormalities such as sialylation levels and/or quality have been recently highlighted. The adjunction of sialic acid at the terminal end of glycoproteins and glycolipids is essential for distinguishing...

Descripción completa

Detalles Bibliográficos
Autores principales: Bordron, Anne, Morel, Marie, Bagacean, Cristina, Dueymes, Maryvonne, Pochard, Pierre, Harduin-Lepers, Anne, Jamin, Christophe, Pers, Jacques-Olivier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036829/
https://www.ncbi.nlm.nih.gov/pubmed/33810246
http://dx.doi.org/10.3390/ijms22073402

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8036829/
https://www.ncbi.nlm.nih.gov/pubmed/33810246
http://dx.doi.org/10.3390/ijms22073402

Ejemplares similares